A detailed history of Farther Finance Advisors, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 114 shares of ARVN stock, worth $2,135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114
Previous 114 -0.0%
Holding current value
$2,135
Previous $2.96 Million 5.2%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$24.46 - $40.4 $122 - $202
5 Added 4.59%
114 $2.96 Million
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $727 - $1,046
20 Added 22.47%
109 $4.4 Million
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $1,262 - $3,767
89 New
89 $3.66 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.